Nunzia Pharmaceutical Stock Earnings Per Share
| NUNZ Stock | USD 0 0.00 0.00% |
Nunzia Pharmaceutical fundamentals help investors to digest information that contributes to Nunzia Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Nunzia Pink Sheet. The fundamental analysis module provides a way to measure Nunzia Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nunzia Pharmaceutical pink sheet.
Nunzia |
Nunzia Pharmaceutical Company Earnings Per Share Analysis
Nunzia Pharmaceutical's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Nunzia Pharmaceutical Earnings Per Share | (0.28) X |
Most of Nunzia Pharmaceutical's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nunzia Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Nunzia Pharmaceutical has an Earnings Per Share of -0.282 times. This is 103.37% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The earnings per share for all United States stocks is 109.04% higher than that of the company.
Nunzia Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nunzia Pharmaceutical's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nunzia Pharmaceutical could also be used in its relative valuation, which is a method of valuing Nunzia Pharmaceutical by comparing valuation metrics of similar companies.Nunzia Pharmaceutical is currently under evaluation in earnings per share category among its peers.
Nunzia Fundamentals
| Return On Asset | -2702.39 | |||
| Current Valuation | 87.59 M | |||
| Shares Outstanding | 434.52 M | |||
| Shares Owned By Insiders | 81.95 % | |||
| EBITDA | (9.02 M) | |||
| Net Income | (9.02 M) | |||
| Cash And Equivalents | 5.07 K | |||
| Total Debt | 139.96 K | |||
| Current Ratio | 0.20 X | |||
| Cash Flow From Operations | (86.78 K) | |||
| Earnings Per Share | (0.28) X | |||
| Beta | -2.57 | |||
| Market Capitalization | 24.88 M | |||
| Total Asset | 5.13 K | |||
| Net Asset | 5.13 K |
About Nunzia Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nunzia Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nunzia Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nunzia Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nunzia Pink Sheet Analysis
When running Nunzia Pharmaceutical's price analysis, check to measure Nunzia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nunzia Pharmaceutical is operating at the current time. Most of Nunzia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Nunzia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nunzia Pharmaceutical's price. Additionally, you may evaluate how the addition of Nunzia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.